Characteristics of patients meeting the new definition of pulmonary hypertension (Nice 2018) in single Japanese PH center.
K. Yamamoto (Chiba, Japan), N. Tanabe (Chiba, Japan), R. Suda (Chiba, Japan), A. Naito (Chiba, Japan), A. Sekine (Chiba, Japan), R. Nishimura (Chiba, Japan), T. Jujo (Chiba, Japan), A. Shigeta (Chiba, Japan), S. Sakao (Chiba, Japan), K. Tatsumi (Chiba, Japan)
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Yamamoto (Chiba, Japan), N. Tanabe (Chiba, Japan), R. Suda (Chiba, Japan), A. Naito (Chiba, Japan), A. Sekine (Chiba, Japan), R. Nishimura (Chiba, Japan), T. Jujo (Chiba, Japan), A. Shigeta (Chiba, Japan), S. Sakao (Chiba, Japan), K. Tatsumi (Chiba, Japan). Characteristics of patients meeting the new definition of pulmonary hypertension (Nice 2018) in single Japanese PH center.. 5468
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
International guidelines for the chronic obstructive pulmonary disease (COPD) and the real therapeutic management of patients in Greece from pulmonologists and general practitioners (GPs) Source: Eur Respir J 2002; 20: Suppl. 38, 398s Year: 2002
What proportion of patients with Idiopathic Pulmonary Fibrosis fall outside UK prescribing criteria for anti-fibrotic treatment? A UK specialist centre review. Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia Year: 2019
Identifying chronic thromboembolic pulmonary hypertension (CTEPH) through French national hospital database (PMSI) Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018
A retrospective audit of chronic obstructive pulmonary disease (COPD) admissions to a university teaching hospital after publication of the British Thoracic Society (BTS) guidelines Source: Eur Respir J 2001; 18: Suppl. 33, 26s Year: 2001
Clinical characteristics of the pulmonary hypertension (PH) in a cardiologist service Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011
Use of prognostic indicators to identify patients with end stage COPD: A survey of South-West (SW) England clinicians Source: Annual Congress 2013 –The best posters in chronic care Year: 2013
Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014
AUDIPOC. National clinical audit on chronic obstructive pulmonary disease exacerbations (eCOPD) in Spain. Experience on mechanical ventilation in patients admitted for eCOPD. Pilot study in six autonomous regions Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure Year: 2009
Cardiovascular diseases (CVD), arterial hypertension (AH) and diabetes mellitus (DM) in a cohort of 609 COPD patients: Associations with the new GOLD classification 2011 Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013
Comparison of characteristics of COPD patients with an established diagnosis, with those newly identified through case-finding – The Birmingham COPD cohort study Source: International Congress 2014 – Highlights in respiratory epidemiology Year: 2014
Current epoprostenol use in patients with severe pulmonary hypertension (PH): Data from the French PH registry Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011
Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs Source: Eur Respir Rev 2009; 18: 18-23 Year: 2009
Regional and practice-based variations in the diagnosis of chronic obstructive pulmonary disease (COPD) unexplained by deprivation, population demographics, and practice list size Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care Year: 2009
Chronic obstructive pulmonary disease (COPD) as co morbidity (CO) in different patient categories in a university hospital setting. A cross sectional study Source: Annual Congress 2012 - COPD comorbidities I Year: 2012
COPD classification according GOLD 2013 and Latin American Thoracic Association (ALAT) recommendations in PUMA study Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing Year: 2016
Longitudinal observation of idiopathic pulmonary fibrosis (IPF) patients cohort from one center in Poland. Source: International Congress 2019 – Interstitial lung disease registries Year: 2019
Socioeconomic position and use of drugs in chronic obstructive pulmonary disease (COPD): A population-based cohort study in Rome, Italy Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011
Clinical and epidemiological characteristics of chronic obstructive pulmonary disease (COPD) patients in Spain (VICE Study) Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006
Investigation of the prevalence of comorbidities in patients with COPD using the Italian college of general practitioners (SIMG) database Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009
Cost-effectiveness of an early supported discharge service (ESDS) for chronic obstructive pulmonary disease (COPD) in a university hospital serving a large rural population Source: Annual Congress 2007 - Ethical and economic choices in respiratory care Year: 2007